Professor Andy Porter FRSB, FRSE

by | Dec 7, 2015 | Team

Andy was one of the founders of Elasmogen and as CTO manages the company’s extensive patent portfolio and IP strategy.  He also holds a number of Non-Exec positions in Life Science and other businesses in Scotland.  Andy is part-time Professor of Medical Biotechnology and Director of the Scottish Biologics Facility, University of Aberdeen.  Since 2005 he has been a Fellow of the Royal Society of Edinburgh and until recently was VP Business.  Andy has worked with academics and companies across the world, developing biologics to a range of diagnostic and therapeutic targets including:  oncology, inflammation, CNS disease and most recently Covid-19.  Andy is a graduate of St Andrews University.